[1]
|
Ljungberg, B. (2004) Prognostic factors in renal cell carcinoma. Scandinavian Journal of Surgery, 93, 118-125.
|
[2]
|
Patel, P.H., Chaganti, R.S. and Motzer, R.J. (2006) Targeted therapy for metastatic renal cell carcinoma. British Journal of Cancer, 94, 614-619.
|
[3]
|
Golimbu, M., Joshi, P., Sperber, A., Tessler, A., Al-Askari, S. and Morales, P. (1986) Renal cell carcinoma: Survival and prognostic factors. Urology, 27, 291-301.
doi:10.1016/0090-4295(86)90300-6
|
[4]
|
Kozlowski, J.M. (1994) Management of distant solitary recurrence in the patient with renal cancer. Contralateral kidney and other sites. The Urologic Clinics of North America, 21, 601-624.
|
[5]
|
Pontes, J.E. (1983) Adjunctive treatment of renal cell carcinoma. International Advances in Surgical Oncology, 6, 309-322.
|
[6]
|
Ritchie, A.W. and De Kernion, J.B. (1987) The natural history and clinical features of renal carcinoma. Seminars in Nephrology, 7, 131-139.
|
[7]
|
Silverberg, E. and Lubera, J. (1987) Cancer statistics, 1987. CA: A Cancer Journal for Clinicians, 37, 2-19.
doi:10.3322/canjclin.37.1.2
|
[8]
|
Motzer, R.J., Bander, N.H. and Nanus, D.M. (1996) Renal-cell carcinoma. The New England Journal of Medicine, 335, 865-875. doi:10.1056/NEJM199609193351207
|
[9]
|
Rabinovitch, R.A., Zelefsky, M.J., Gaynor, J.J. and Fuks, Z. (1994) Patterns of failure following surgical resection of renal cell carcinoma: Implications for adjuvant local and systemic therapy. Journal of Clinical Oncology, 12, 206-212.
|
[10]
|
Sandock, D.S., Seftel, A.D. and Resnick, M.I. (1995) A new protocol for the followup of renal cell carcinoma based on pathological stage. The Journal of Urology, 154, 28-31. doi:10.1016/S0022-5347(01)67215-X
|
[11]
|
Skinner, D.G., Colvin, R.B., Vermillion, C.D., Pfister, R.C. and Leadbetter, W.F. (1971) Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer, 28, 1165-1177.
doi:10.1002/1097-0142(1971)28:5<1165::AID-CNCR2820280513>3.0.CO;2-G
|
[12]
|
Murthy, S.C., Kim, K., Rice, T.W., et al. (2005) Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma? The Annals of Thoracic Surgery, 79, 996-1003.
doi:10.1016/j.athoracsur.2004.08.034
|
[13]
|
Pfannschmidt, J., Hoffmann, H., Muley, T., Krysa, S., Trainer, C. and Dienemann, H. (2002) Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma. The Annals of Thoracic Surgery, 74, 1653-1657. doi:10.1016/S0003-4975(02)03803-1
|
[14]
|
Calle, E.E., Rodriguez, C., Walker-Thurmond, K. and Thun, M.J. (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. The New England Journal of Medicine, 348, 1625-1638.
doi:10.1056/NEJMoa021423
|
[15]
|
Lindblad, P., Chow, W.H., Chan, J., et al. (1999) The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia, 42, 107-112. doi:10.1007/s001250051122
|
[16]
|
Setiawan, V.W., Stram, D.O., Nomura, A.M., Kolonel, L.N. and Henderson, B.E. (2007) Risk factors for renal cell cancer: The multiethnic cohort. American Journal of Epidemiology, 166, 932-940. doi:10.1093/aje/kwm170
|
[17]
|
Zucchetto, A., Dal Maso, L., Tavani, A., et al. (2007) History of treated hypertension and diabetes mellitus and risk of renal cell cancer. Annals of Oncology, 18, 596-600.
doi:10.1093/annonc/mdl438
|
[18]
|
Helmrich, S.P., Ragland, D.R., Leung, R.W. and Paffenbarger, R.S Jr. (1991) Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. The New England Journal of Medicine, 325, 147-152.
doi:10.1056/NEJM199107183250302
|
[19]
|
Mokdad, A.H., Ford, E.S., Bowman, B.A., et al. (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. The Journal of the American Medical Association, 289, 76-79. doi:10.1001/jama.289.1.76
|
[20]
|
Landsberg, L. (2005) Insulin resistance and the metabolic syndrome. Diabetologia, 48, 1244-1246.
doi:10.1007/s00125-005-1818-z
|
[21]
|
Biggs, M.L., Mukamal, K.J., Luchsinger, J.A., et al. (2010) Association between adiposity in midlife and older age and risk of diabetes in older adults. The Journal of the American Medical Association, 303, 2504-2512.
doi:10.1001/jama.2010.843
|
[22]
|
Waalkes, S., Merseburger, A.S., Kramer, M.W., et al. (2010) Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer. Cancer Causes Control, 21, 1905-1910.
doi:10.1007/s10552-010-9618-2
|
[23]
|
Schrader, A.J., Sevinc, S., Olbert, P.J., Hegele, A., Varga, Z. and Hofmann, R. (2008) Gender-specific characteristics and survival of renal cell carcinoma. Urologe A, 47, 1182, 1184-1186. doi:10.1007/s00120-008-1832-0
|
[24]
|
Chow, W.H., Gridley, G., Fraumeni, J.F. Jr. and Jarvholm, B. (2000) Obesity, hypertension, and the risk of kidney cancer in men. The New England Journal of Medicine, 343, 1305-1311. doi:10.1056/NEJM200011023431804
|
[25]
|
Moyad, M.A. (2001) Obesity, interrelated mechanisms, and exposures and kidney cancer. Seminars in Urologic Oncology, 19, 270-279.
|
[26]
|
Wolk, A., Gridley, G., Niwa, S., et al. (1996) International renal cell cancer study. VII. Role of diet. International Journal of Cancer, 65, 67-73.
doi:10.1002/(SICI)1097-0215(19960103)65:1<67::AID-IJC12>3.0.CO;2-F
|
[27]
|
Wolk, A., Lindblad, P. and Adami, H.O. (1996) Nutrition and renal cell cancer. Cancer Causes Control, 7, 5-18.
doi:10.1007/BF00115634
|
[28]
|
Everhart, J. and Wright, D. (1995) Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. The Journal of the American Medical Association, 273, 1605-1609.
doi:10.1001/jama.273.20.1605
|
[29]
|
Wolf, I., Sadetzki, S., Catane, R., Karasik, A. and Kaufman, B. (2005) Diabetes mellitus and breast cancer. The Lancet Oncology, 6, 103-111.
doi:10.1016/S1470-2045(05)01736-5
|
[30]
|
Constance, S., Sixta, F. and Ostwald, S. (2008) Texas-Mexico border intervention by promotores for patients with type 2 diabetes. The Diabetes Educator, 34, 299-309.
doi:10.1177/0145721708314490
|